Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Repligen Corporation    RGEN

REPLIGEN CORPORATION

(RGEN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/11/2021 01/12/2021 01/13/2021 01/14/2021 01/15/2021 Date
205.89(c) 206.33(c) 207.97(c) 212.25(c) 215.47(c) Last
416 530 430 474 302 781 619 435 417 738 Volume
-1.19% +0.21% +0.79% +2.06% +1.52% Change
More quotes
Financials (USD)
Sales 2020 352 M - -
Net income 2020 49,6 M - -
Net cash position 2020 224 M - -
P/E ratio 2020 232x
Yield 2020 -
Sales 2021 455 M - -
Net income 2021 66,3 M - -
Net cash position 2021 314 M - -
P/E ratio 2021 183x
Yield 2021 -
Capitalization 11 710 M 11 710 M -
EV / Sales 2020 32,7x
EV / Sales 2021 25,0x
Nbr of Employees -
Free-Float 92,9%
More Financials
Company
Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It provides Protein A ligands, a component of Protein A chromatography resins (media) used... 
More about the company
Notations Surperformance© of Repligen Corporation
Trading Rating : Investor Rating :
More Ratings
All news about REPLIGEN CORPORATION
01/06INSIDER TRENDS : Insider 90-Day Selling Trend Added to at Repligen
MT
01/04Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Confere..
GL
2020Repligen Corporation Announces Closing of Public Offering of $312.2 Million, ..
GL
2020REPLIGEN CORP : Entry into a Material Definitive Agreement, Other Events, Financ..
AQ
2020REPLIGEN : EC Mergers & Acquisitions advised ARTeSYN on its Sale to Repligen
PR
2020Repligen Prices $271.5 Million Public Offering
MT
2020Repligen Corporation Prices Public Offering of Shares of Common Stock
GL
2020Repligen Corporation Announces Proposed Public Offering of Shares of Common S..
GL
2020INSIDER TRENDS : Repligen Insider Continues 90-Day Selling Trend
MT
2020KeyBanc Starts Repligen at Overweight with $241 Price Target
MT
2020REPLIGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
2020REPLIGEN : 3Q Earnings Snapshot
AQ
2020REPLIGEN CORP : Results of Operations and Financial Condition, Financial Stateme..
AQ
2020Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q3 EPS $0.40, vs. Street Est..
MT
2020Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q3 Revenue $94.1M, vs. Str..
MT
More news
News in other languages on REPLIGEN CORPORATION
2014REPLIGEN CORPORATION : publication des résultats trimestriels
2013REPLIGEN CORPORATION : publication des résultats trimestriels
More news
Analyst Recommendations on REPLIGEN CORPORATION
More recommendations
Stock Trading Strategies
REPLIGEN CORPORATION - 2020
Increase of volatility
BUY
More Stock Trading Analysis
Chart REPLIGEN CORPORATION
Duration : Period :
Repligen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REPLIGEN CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 217,71 $
Last Close Price 215,47 $
Spread / Highest target 11,8%
Spread / Average Target 1,04%
Spread / Lowest Target -19,2%
EPS Revisions
Managers and Directors
NameTitle
Tony J. Hunt President, Chief Executive Officer & Director
Karen A. Dawes Chairman
Steve Curran Vice President-Global Operations
Jon K. Snodgres Secretary, Chief Financial & Accounting Officer
Ralf Kuriyel Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
REPLIGEN CORPORATION12.44%11 710
ABBOTT LABORATORIES1.65%190 701
MEDTRONIC PLC-0.28%157 229
BECTON, DICKINSON AND COMPANY4.60%76 127
HOYA CORPORATION-2.24%50 041
ALIGN TECHNOLOGY, INC.6.15%44 726